Apple Watch: US imports of some Apple Watches banned while patent case plays out
Amid a legal clash with medical tech firm Masimo, a U.S. appeals court bans Apple from selling Series 9 and Ultra 2 Apple Watches featuring a disputed blood oxygen feature. Apple's shares dip 0.5%, and analysts predict a potential year-long legal battle. As Apple faces the import ban, constituting a quarter of the global smartwatch market, industry watchers anticipate the disabling of the contentious feature, temporarily complying with the ruling. The court decision underscores the importance of respecting intellectual rights, signaling potential repercussions for patent infringement.